Humacyte, Inc. - Common Stock (NQ:HUMA)

0.4435 -0.0288 (-6.10%)

Delayed Quote Updated: 1:01 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Humacyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

March 26, 2025

Via Benzinga

Top movers in Tuesday's after hours session ↗

March 25, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 25, 2025

Via Benzinga

Humacyte Shares Plunge After Hours: Here's Why ↗

March 25, 2025

Humacyte shares are tumbling in Tuesday's after-hours session after the company announced a proposed public offering.

Via Benzinga

Trestle Bio Announces Research Collaboration with Humacyte

March 06, 2025

From Trestle Biotherapeutics, Inc.

Via Business Wire

HUMACYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Humacyte, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

January 23, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm

January 17, 2025

From The Schall Law Firm

Via Business Wire

HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

January 17, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

Faruqi & Faruqi Reminds Humacyte Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA

January 17, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm

January 16, 2025

From Schall Law

Via GlobeNewswire

Deadline Soon: Humacyte, Inc. (HUMA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

January 15, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

HUMA DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

January 14, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wolfspeed, Xerox, Visa, and Humacyte and Encourages Investors to Contact the Firm

January 13, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Humacyte, Inc. Investors of Upcoming Deadline

January 13, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

January 10, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Humacyte, Inc. Investors of Upcoming Deadline

January 07, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PACS Group, Chipotle, Hasbro, and Humacyte and Encourages Investors to Contact the Firm

January 06, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Kirby McInerney LLP Urges Investors in Humacyte, Inc. to Inquire About Their Rights in Class Action Lawsuit

December 31, 2024

From Kirby McInerney LLP

Via Business Wire

DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Humacyte to Contact Us to Have Their Losses Evaluated Today

December 31, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

December 30, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Humacyte, Inc. Investors of Upcoming Deadline

December 30, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

HUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the Firm

December 26, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

HUMA Lead Plaintiff Deadline Approaching – Contact Robbins LLP for Information About the Class Action Against Humacyte, Inc.

December 24, 2024

From Robbins LLP

Via GlobeNewswire

HUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the Firm

December 23, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Microsoft To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday ↗

December 23, 2024

Via Benzinga

HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Humacyte, Inc. Investors of Upcoming Deadline

December 23, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

December 20, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 20, 2024

Via Benzinga

Dow Surges Over 600 Points, Gold Jumps 1.5% ↗

December 20, 2024

Via Benzinga

Topics Stocks

Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher ↗

December 20, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.